Exagen Inc. Reports Quarterly Results for Period Ended Mar 31, 2026

What Happened
Exagen Inc. (XGN) filed a Form 8-K on May 11, 2026 (Item 2.02) to report its results of operations and financial condition for the three months ended March 31, 2026. The company furnished a press release announcing those quarterly results as Exhibit 99.1 to the filing.

Key Details

• Filing date: May 11, 2026; reporting period: three months ended March 31, 2026.
• The press release with the quarterly results is furnished as Exhibit 99.1 to the Form 8-K.
• The filing includes an Inline XBRL cover page (Exhibit 104) for interactive data.

Why It Matters
Quarterly results provide investors with updated information on Exagen’s revenue, earnings and financial condition; the press release filed with this 8-K is the primary source for those specific figures. Retail investors should review the furnished press release and any subsequent SEC filings (e.g., quarterly reports) for the detailed financial metrics and management commentary before making investment decisions.